Table 3

Central macular thickness after intravitreal injection in the IVB and IVB/IVF groups

ParameterTotalGroupDifference95%CIP values
Month 3
Change (baseline—3)
Month 6
Change (baseline—6)
  • *Based on t-test.

  • †Adjusted for the baseline, based on analysis of covariance.

  • ‡Based on linear mixed model, multiple comparison considered by Bonferroni method.

  • IVB, intravitreal injection of bevacizumab; IVB/IVF, intravitreal injection of both bevacizumab and fasudil.